E-LIB Suche - Ergebnisse für: Constantine-Cooke, N

1

P860 Long-term outcomes and predictors of vedolizumab persi..:

Gros, B ; Ross, H ; Nwabueze, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1592-i1594 , 2024

Link: https://doi.org/10.1093/..

2

P823 Real-world effectiveness of upadacitinib in Crohn's di..:

Elford, A ; Bishara, M ; Plevris, N...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1533-i1535 , 2024

Link: https://doi.org/10.1093/..

3

DOP17 Tofacitinib versus Vedolizumab Among Bio-naïve Patien..:

Gros, B ; Constantine-Cooke, N ; Kennedy, J...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i102-i103 , 2024

Link: https://doi.org/10.1093/..

4

P745 Multiple infliximab biosimilar switches appear to be s..:

Gros, B ; Plevris, N ; Constantine-Cooke, N...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i876-i876 , 2023

Link: https://doi.org/10.1093/..

5

P557 Analysis of colectomy rates and advanced therapy presc..:

Jenkinson, P ; Plevris, N ; Gros Alcalde, B...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i687-i689 , 2023

Link: https://doi.org/10.1093/..

6

P509 Surgery and biologic prescription rates for Crohn's di..:

Jenkinson, P ; Plevris, N ; Lyons, M...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i640-i640 , 2023

Link: https://doi.org/10.1093/..

7

P789 Inflammatory Bowel Disease subgroups identified by lon..:

Constantine-Cooke, N ; Monterrubio-Gómez, K ; Plevris, N...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i921-i924 , 2023

Link: https://doi.org/10.1093/..

8

P489 Temporal trends of colectomy for ulcerative colitis in..:

Jenkinson, P ; Plevris, N ; Lyons, M...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i455-i456 , 2022

Link: https://doi.org/10.1093/..

9

P330 Long-term outcomes following a switch from originator ..:

Derikx, L ; Dolby, H ; Plevris, N...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S353-S354 , 2021

Link: https://doi.org/10.1093/..

10

P154 Faecal calprotectin and patient reported disease contr..:

Siakavellas, S ; Derikx, L ; Derr, L...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S233-S234 , 2021

Link: https://doi.org/10.1093/..

11

OP22 Factors independently associated with fatigue in IBD: ..:

Derikx, L ; Siakavellas, S ; Derr, L...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S021-S021 , 2021

Link: https://doi.org/10.1093/..

12

P117 Patient perceptions about causes of flare in IBD: resu..:

Siakavellas, S ; Derikx, L ; Derr, L...
Journal of Crohn's and Colitis. 15 (2021) Supplement_1 - p. S209-S209 , 2021

Link: https://doi.org/10.1093/..

13

Contributors:

, In: Sperling Pediatric Endocrinology,

Aungst, Heide ; Backeljauw, Philippe ; Baron, Jeffrey... - p. ix-xii , 2021

Link: https://doi.org/10.1016/..

14

Real-world effectiveness of upadacitinib in Crohn's disease..:

Elford, Alexander Thomas ; Bishara, Maria ; Plevris, Nikolas...
Frontline Gastroenterology. 15 (2024) 4 - p. 297-304 , 2024

Link: https://doi.org/10.1136/..

15

Tu1881 REAL-WORLD EFFECTIVENESS OF UPADACITINIB IN CROHN'S ..:

Elford, Alexander T. ; Bishara, Maria ; Plevris, Nikolas...
Gastroenterology. 166 (2024) 5 - p. S-1451-S-1452 , 2024

Link: https://doi.org/10.1016/..